Will MMYT utilize 80%+ of the $100M FY27 buyback annual cap (i.e., $80M+ repurchases) by March 31, 2027?

Q3 FY26 alone hit $46.1M utilization — annualized that's $184M, well above the $80M threshold. Management raised annual cap from $60M to $100M signaling intent to execute. Stock at $46 (29% drawdown) creates buyback economics. Cash position $835M+ supports execution. 2030 notes addition expands toolkit. Trip.com competitor pivot creates defensive-signaling incentive. Major risks: (a) stock appreciation reduces economics, (b) major M&A or AI investment, (c) FX or operational miss. Net: $80M+ FY27 utilization is achievable; main risk is stock spike making economics less attractive. Probability YES: 65%.

I weight the historical base rate higher. MMYT's full-year buyback execution has historically been at 30-50% of authorized cap. Q3 FY26 was $46.1M — highest in MMYT history — but that's a single quarter, not a sustained pace. Full-year typically has 1-2 strong quarters and 2-3 weak quarters due to blackouts and execution timing. The cap was just raised, and management discipline against operational needs (AI/M&A) may temper utilization. Plus Indian regulatory windows have specific quiet-period restrictions. Q3's high pace may not repeat. Net: 80% utilization of new cap is possible but not central case. Probability YES: 55%.

Fresh authorization expansion + opportunistic price + 2030 notes flexibility = high probability of $80M+. The historical 30-50% utilization rate was on the OLD $60M cap (so $20-30M actual). The NEW $100M cap with explicit signal of intent should land $70-90M+ even at 70-90% utilization. Q3 FY26's $46.1M shows management has the operational machinery to execute at pace. Probability YES: 62%.

Recent acceleration is encouraging but the threshold ($80M = 80% of new cap) is at the higher end of typical execution. Q3 FY26 alone was $46.1M but that was opportunistic on the drawdown. Probability of sustaining $20M+ per quarter for 4 consecutive quarters is moderate. Likely outcomes: 60-90% utilization range is most probable, with $80M threshold landing roughly at the median. Probability YES: 58%.

Lean slightly YES. The capital allocation framework supports aggressive utilization at current valuation but there are competing capital needs. AI investment, potential M&A, working capital all compete with buyback. Stock appreciation could reduce buyback economics. The threshold of $80M is meaningful — requires sustained $20M+ per quarter. Probability YES: 55%.

$80M is achievable. The cap was raised specifically to enable aggressive execution. Q3 FY26 at $46M demonstrates capability. 2030 notes purchase flexibility enables alternative deployment. Stock at $46 is attractive. Main risks: rerate above $55-60 reduces economics, M&A/AI capital diversion. Probability YES: 60%.

Q3 FY26 alone was $46.1M — annualized exceeds $80M threshold easily. Cap raise signals intent. Stock at attractive level. Probability YES: 60%.

Lean YES with moderate conviction. $80M utilization requires sustained quarterly pace. Q3 was peak quarter. Full year likely lands $70-100M range. Probability YES: 55%.

Fresh authorization + opportunistic price + Q3 demonstrated pace = lean YES. Risk: capital diversion to AI/M&A or stock rerate. Probability YES: 58%.